Effectiveness & Safety Evaluation of Aqueduct -100 Device

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The purpose of the present clinical investigation is to collect data regarding the safety and effectiveness of the Aqueduct 100 device.

The effectiveness of the Aqueduct 100 will be determined by evaluating the ability to reach desired cervical dilation, and the time frame required to reach desired cervical dilation.

NCT number	NCT02851953
Study type	Interventional
Source	Aqueduct Medical Ltd
Contact
Status	Completed
Phase	N/A
Start date	June 2016
Completion date	January 2017

	Status	Clinical Trial	Phase
	Not yet recruiting	`NCT02959567` - Effectiveness and Safety Evaluation of Aqueduct 100-device	N/A
	Completed	`NCT02941211` - Effectiveness and Safety Evaluation of Aqueduct -100 Device	N/A

Effectiveness and Safety Evaluation of Aqueduct -100 Device

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms